NovoCure Limited logo

NovoCure Limited Investor Relations Material

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. It provides Tumor Treating Fields (TTFields), which are characterized by low-intensity, high-frequency oscillating electric fields that disrupt cell division. The company offers TTFields delivery systems to deliver low intensity alternating electric fields in combination with standard of care chemotherapy

Upcoming events for

Q3 20222022-10-28

Latest company events

Ticker symbol

NVCR

Country

United States of America

About the company

https://www.novocure.com/

Dig deeper into the NovoCure Limited fundamentals on Quartr.

  • Skip straight to the Q&A session
  • Receive notifications about new events
  • Connect the financial calender on your phone
  • Figure out why the stock is up or down
  • Read the transcripts or scroll the deck
  • Access earnings or press releases
App store link
Android play link
Quartr app screenshot